Boldenone and LGD-4033 Interaction

Synergistic
Mechanism-based 60% confidence

Boldenone and LGD-4033 have a synergistic interaction with 60% confidence. LGD-4033 helps manage estrogen conversion from Boldenone. This is a common and recommended combination. Adjust AI dose based on bloodwork — avoid crashing estrogen. Both compounds affect the gonads and heart and liver, so monitoring these systems is recommended.

Compound Profiles

Boldenone

Anabolic-Androgenic Steroid | Lean Mass & Vascularity

Boldenone exerts its anabolic effects primarily through binding to the androgen receptor (AR), promoting nitrogen retention, protein synthesis, and increased IGF-1 output in muscle tissue. The 1,2-double bond modification reduces the compound's affinity for 5-alpha reductase, meaning boldenone is not efficiently converted to a more potent dihydro-metabolite in the way testosterone is converted to DHT.

Half-life: ~14 days (undecylenate) Typical dose: 200-400 mg/week (moderate) anabolic
5 alpha reductaseandrogen receptoraromataseepo receptor androgenicaromatase inhibitorblood pressure raisingcarcinogenic risk
View full profile

LGD-4033

Selective Androgen Receptor Modulator | Lean Mass

LGD-4033 binds to the androgen receptor with high affinity (Ki of approximately 1 nM), functioning as a potent and selective agonist in muscle and bone tissue. Like other SARMs, its tissue selectivity is mediated by differential cofactor recruitment: upon binding to the AR, LGD-4033 induces a receptor conformation that preferentially recruits coactivators expressed in skeletal muscle and bone, while showing minimal agonist activity in androgen-sensitive tissues such as the prostate and skin.

Half-life: ~24-36 hours Typical dose: 5-10 mg/day sarm, anabolic
androgen receptorepo receptor androgenicblood pressure raisingcarcinogenic riskestrogenic
View full profile

Combined Organ Load

Gonads
elevated
Heart
moderate
Liver
moderate

Shared Safety Flags

2x 2 androgenic compounds (Boldenone, LGD-4033). Additive androgenic load — increased risk of hair loss, acne, prostate effects.
2x 2 compounds raise blood pressure (Boldenone, LGD-4033). Monitor BP daily and consider cardiovascular support.
2x 2 compounds share the carcinogenic-risk safety flag (Boldenone, LGD-4033). Monitor accordingly.
2x 2 estrogenic compounds (Boldenone, LGD-4033). Combined estrogen elevation — monitor E2 and consider aromatase inhibitor.
2x 2 HPTA-suppressive compounds (Boldenone, LGD-4033). Deep hormonal shutdown expected — plan extended PCT.
2x 2 compounds disrupt lipids (Boldenone, LGD-4033). Get lipid panel mid-cycle — consider adding lipid support.
2x 2 compounds share the teratogenic safety flag (Boldenone, LGD-4033). Monitor accordingly.

Frequently Asked Questions

Can I take Boldenone with LGD-4033?

Yes, Boldenone and LGD-4033 can generally be taken together. LGD-4033 helps manage estrogen conversion from Boldenone. This is a common and recommended combination. Adjust AI dose based on bloodwork — avoid crashing estrogen.

Is Boldenone and LGD-4033 safe together?

Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: androgenic, blood pressure raising, carcinogenic risk, estrogenic, hpta suppressive, lipid disrupting, teratogenic. Monitor accordingly.

What are the interactions between Boldenone and LGD-4033?

LGD-4033 helps manage estrogen conversion from Boldenone. This is a common and recommended combination. Adjust AI dose based on bloodwork — avoid crashing estrogen. This assessment has 60% confidence and is inferred from pharmacological mechanism analysis.

How should I time Boldenone and LGD-4033?

Boldenone has a half-life of ~14 days (undecylenate) and LGD-4033 has a half-life of ~24-36 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Boldenone vs LGD-4033

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.